A verification study of proposed pelvic lymph node localisation guidelines using nanoparticle-enhanced magnetic resonance imaging.
暂无分享,去创建一个
R. Reznek | A. Rockall | Maria J Vilarino-Varela | Alexandra Taylor | Andrea G Rockall | Rodney H Reznek | Melanie E B Powell | M. Powell | M. Vilarino-Varela | Alexandra Taylor
[1] John C Roeske,et al. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. , 2002, International journal of radiation oncology, biology, physics.
[2] T. Cheung,et al. Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. , 2000, AJR. American journal of roentgenology.
[3] J. Buatti,et al. Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic cancer? , 2003, International journal of radiation oncology, biology, physics.
[4] J. Roeske,et al. Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies. , 2000, International journal of radiation oncology, biology, physics.
[5] Patrick M M Bossuyt,et al. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. , 2003, Gynecologic oncology.
[6] J A Koutcher,et al. AMI-227-enhanced MR lymphography: usefulness for differentiating reactive from tumor-bearing lymph nodes. , 1994, Radiology.
[7] N. Sakuragi,et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy , 1999, Cancer.
[8] N. deSouza,et al. Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography. , 2001, AJR. American journal of roentgenology.
[9] S. Kalnicki,et al. Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms. , 2003, Gynecologic oncology.
[10] G. Marchal,et al. Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) – results of a phase-III multicenter clinical trial , 2002, European Radiology.
[11] M. Harisinghani,et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] J Williamson,et al. Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. , 1999, International journal of radiation oncology, biology, physics.
[13] G. Scambia,et al. Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy. , 1996, Gynecologic oncology.
[14] John C Roeske,et al. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. , 2003, International journal of radiation oncology, biology, physics.
[15] M R Segal,et al. Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. , 1997, JAMA.
[16] D P Dearnaley,et al. Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer. , 2000, International journal of radiation oncology, biology, physics.
[17] A. Darzi,et al. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. , 2006, The Lancet. Oncology.
[18] K. Eichler,et al. Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. , 2002, Radiology.
[19] Chun-Chieh Wang,et al. Recurrent squamous cell carcinoma of cervix after definitive radiotherapy. , 2004, International journal of radiation oncology, biology, physics.
[20] K. Chao,et al. Lymphangiogram-assisted lymph node target delineation for patients with gynecologic malignancies. , 2002, International journal of radiation oncology, biology, physics.
[21] B. Marincek,et al. USPIO-enhanced MRI for preoperative staging of gynecological pelvic tumors: preliminary results , 2004, European Radiology.
[22] D Low,et al. Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. , 2001, International journal of radiation oncology, biology, physics.
[23] R. Reznek,et al. Mapping pelvic lymph nodes: guidelines for delineation in intensity-modulated radiotherapy. , 2005, International journal of radiation oncology, biology, physics.
[24] A. Rockall,et al. An atlas of the pelvic lymph node regions to aid radiotherapy target volume definition. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).
[25] D. Koh,et al. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings--initial observations. , 2004, Radiology.
[26] M. Taupitz,et al. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. , 2004, Radiology.
[27] Ralph Weissleder,et al. Mapping of nodal disease in locally advanced prostate cancer: rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy. , 2004, International journal of radiation oncology, biology, physics.